A tolvaptan skeptic repents

Affiliations

Free article

Comment

Brad H Rovin. Kidney Int. 2020 Aug.

Free article

. 2020 Aug;98(2):293.

doi: 10.1016/j.kint.2020.04.005.

¹ Internal Medicine-Nephrology, Ohio State University, Columbus, Ohio, USA. Electronic address: Brad.Rovin@osumc.edu.

No abstract available

Comment on

Tolvaptan or transplant: why wait?
Gordon CE, Perrone RD. Gordon CE, et al. Kidney Int. 2020 Aug;98(2):286-289. doi: 10.1016/j.kint.2020.03.022. Kidney Int. 2020. PMID: 32709289 No abstract available.
Vasopressin V2 receptor antagonists in autosomal dominant polycystic kidney disease: efficacy, safety, and tolerability.
Meijer E, Gansevoort RT. Meijer E, et al. Kidney Int. 2020 Aug;98(2):289-293. doi: 10.1016/j.kint.2020.03.023. Kidney Int. 2020. PMID: 32709290 No abstract available.